Thyroid transcription factor 1 and Napsin A double stain: Utilizing different vendor antibodies for diagnosing lung adenocarcinoma

Acta Cytologica

Volumn 56, Issue 6, 2012, Pages 596-602

  Johnson, Hunter ^a   Cohen, Cynthia ^a   Fatima, Nazneen ^a   Duncan, David ^b   Siddiqui, Momin T ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b Leica Biosystems NCL Ltd   (United Kingdom)

Author keywords

Fine needle aspiration; Immunohistochemistry; Lung cancer; Napsin A; Thyroid transcription factor 1

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; NAPSIN A; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ARTICLE; ASPIRATION CYTOLOGY; CANCER DIAGNOSIS; CYTOPLASM; DIAGNOSTIC TEST ACCURACY STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL; LUNG CANCER; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THYROID FOLLICLE CELL;

EID: 84870725564     PISSN: 00015547     EISSN: None     Source Type: Journal    
DOI: 10.1159/000339793     Document Type: Article

References (21)

1. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y: The new World Health Organization Classification of lung tumours. Eur Respir J 2001; 18: 1059-1068. (Pubitemid 34092881)
2. Travis WD: Pathology of lung cancer. Clin Chest Med 2002; 23: 65-81. (Pubitemid 34207764)
3. American Cancer Society: Cancer Facts & Figures 2004. 2005. http://www.cancer.org/docroot/STT/stt-0-2004.asp?sitearea= SST&level=1.
4. Travis WD, Brambilla E, Noguchi M, et al: International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011; 6: 244-285.
5. Hirsch FR, Speafico A, Novello S, et al: The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review. J Thorac Oncol 2008; 3: 1468-1481.
6. Asami K, Koizumi T, Hirai K, et al: Gefitinib as first-line treatment in elderly epidermal growth factor receptor-mutated patients with advanced lung adenocarcinoma: results of a Nagano Lung Cancer Research Group Study. Clin Lung Cancer 2011; 12: 387-392.
7. Reck M, Barlesi F, Crino L, et al: Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts. Ann Oncol 2012; 23: 1111-1120.
8. Hecht JL, Pinkus JL, Weinstein LJ, Pinkus GS: The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Am J Clin Pathol 2001; 116: 483-488. (Pubitemid 34450281)
9. Suzuki A, Shijubo N, Yamada G, et al: Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs. Pathol Res Pract 2005; 201: 579-586. (Pubitemid 41363952)
10. Fatima N, Cohen C, Lawson D, Siddiqui MT: TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks. Cancer Cytopathol 2011; 119: 127-133.
11. Travis WD, Rekhtman N, Riley GJ, et al: Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift. J Thorac Oncol 2010; 5: 411-414.
12. Coghlin CL, Smith LJ, Bakar S, et al: Quantitative analysis of tumor in bronchial biopsy specimens. J Thorac Oncol 2010; 5: 448-452.
13. Edwards SL, Roberts C, McKean ME, et al: Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category. J Clin Pathol 2000; 53: 537-540. (Pubitemid 30432112)
14. Ocque R, Tochiqi N, Paul Ohori N, Dacic S: Usefullness of immunohistochemical and histochemical studies in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens. Am J Clin Pathol 2011; 136: 81-87.
15. Liu J, Farhood A: Immunostaining for thyroid transcription factor-1 on fine needle aspiration specimens of lung tumors. Cancer Cytopathol 2004; 102: 109-114.
16. Bishop JA, Sharma R, Illei PB: Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol 2010; 41: 20-25.
17. Kim JH, Kim YS, Choi YD, et al: Utility of napsin a and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion. Acta Cytologica 2011; 55: 266-270.
18. Ordonez NG: Napsin A expression in lung and kidney neoplasia: a review and update. Adv Anat Pathol 2012; 19: 66-73.
19. Matoso A, Singh K, Jacob R, et al: Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors. Appl Immunohistochem Mol Morphol 2010; 18: 142-149.
20. Penman D, Downie I, Roberts F: Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution. J Clin Pathol 2006; 59: 663-664. (Pubitemid 43886055)
21. Comperat E, Zhang F, Perrotin C, et al: Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin. Mod Pathol 2005; 18: 1371-1376. (Pubitemid 41348657)